Patent · US Active

Sulfated benzimidazolone derivatives having mixed serotonin receptor affinity

US8722682B2 · kind B2 · utility

11Cited by

10References

6Claims

0Family size

Assignee

Sprout Pharmaceuticals, Inc. · US

Inventors

Astrid Volz · Ingelheim am Rhein, DE
Ralf Lotz · Schemmerhofen, DE
Fabio Paleari · Monza, IT

Key dates

Filing date	Dec 18, 2007
Grant date	May 13, 2014
Priority date	—
Expiry date	Mar 20, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention pertains to a compound of formula (I)wherein R1, R2, R3, and R4 are each hydrogen or sulfate monoester with the proviso that R1, R2, R3, and R4 cannot simultaneously be hydrogen, processess for their preparation and their use as pharmaceuticals in the treatment of CNS disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.